Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Natera, Inc. (NTRA)

Natera director Monica Bertagnolli resigns from board effective July 1, 2026

Neutral Impact 2 of 5 leadership Written later

Natera director Monica Bertagnolli notified the board on July 1, 2026, that she would resign from the board and all its committees, effective the same day, citing a new position with the National Academy of Medicine. The filing states her resignation did not stem from any disagreement with the company on its operations, policies or practices.

Key points

  • Monica Bertagnolli resigned from the Natera board and all committees, effective July 1, 2026
  • Reason given: new position with the National Academy of Medicine
  • Filing states no disagreement with the company on operations, policies or practices
  • Disclosed in Form 8-K dated July 6, 2026, signed by CFO Michael Brophy

The filing

CompanyNatera, Inc. (NTRA)
Form8-K, current report
Filed with the SECJul 6, 2026, 4:05 PM ET
Accession number0001604821-26-000005

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 06, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.